[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588656":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":18,"locations":25,"responsibleParty":39,"collaborators":10,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":45,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":10,"studyType":57,"phases":10,"briefSummary":58,"conditions":59,"keywords":10,"overallStatus":63,"whyStopped":10,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Gaziantep","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"1",null,"All eligible participants aged 30-79 years enrolled from a single family health center in Gaziantep, Türkiye. All participants will undergo anthropometric measurements and be classified into CKM Syndrome stages (0-4) based on clinical and laboratory data. This is a single-group observational study; subgrouping will occur only during analysis.",[13],"Other: No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment.",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":10},"No intervention is applied. This is a non-interventional, observational study. Anthropometric measurements and existing laboratory data are used for CKM staging and risk assessment.",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":23,"email":24},"Yıldız Büyükdereli Atadağ, Asst Prof","CONTACT","+903423601200","76148","yildizatadag@gantep.edu.tr",[26],{"facility":27,"status":10,"city":28,"state":10,"zip":29,"country":30,"countryCode":10,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Bağlarbaşı Family Health Center","Gaziantep","27900","Turkey (Türkiye)",{"type":32,"coordinates":33},"Point",[34,35],37.3825,37.05944,{"lat":35,"lon":34},[38],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":24},{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Yildiz Büyükdereli Atadag","Asst. Prof.","100588656","ckm-syndrome-prevalence-and-its-association-with-score-2-and-bri-100588656",false,"NCT06944236","CKM Syndrome Prevalence and Its Association With SCORE-2 and BRI","Prevalence of Cardiovascular-Kidney-Metabolic (CKM) Syndrome and Its Relationship With SCORE-2 Risk Score and Body Roundness Index (BRI): A Study From Gaziantep, Turkey","CKM-PREV","Inclusion Criteria Age between 30 and 79 years Residence in Gaziantep, Türkiye\n\nAvailability of the following laboratory tests performed within the past 1 month:\n\nFasting glucose HbA1c Lipid profile (total cholesterol, LDL, HDL, triglycerides) Creatinine Estimated glomerular filtration rate (eGFR) Ability to provide informed consent\n\nExclusion Criteria Presence of severe physical or mental disability Hospitalization due to acute illness within the past 3 months Pregnancy","ALL","30 Years","79 Years",{"count":55,"type":56},400,"ESTIMATED","OBSERVATIONAL","This cross-sectional study aims to determine the prevalence of Cardiovascular-Kidney-Metabolic (CKM) syndrome in a community-based adult population in Gaziantep, Türkiye. In addition to estimating the prevalence across CKM stages, the study investigates the associations between CKM syndrome and two key risk indicators: the SCORE-2 cardiovascular risk score and Body Roundness Index (BRI). Findings from this study will provide valuable insights into early cardiometabolic risk profiling and support the development of regionally tailored prevention strategies.",[60,61,62],"Metabolic Syndrome","Cardiovascular Diseases","Chronic Kidney Disease(CKD)","NOT_YET_RECRUITING","2025-04-17",{"date":66,"type":67},"2025-04-25","ACTUAL",{"date":69,"type":56},"2025-06-01",{"date":71,"type":56},"2025-12-31",{"name":5,"class":6},1]